{"id":214938,"title":"Summary: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series: NACI, June 9, 2023 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:50:52.410000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html?wbdisable=false","snippet":"Summary: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series: NACI, June 9, 2023 - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu…","rawSnapshotUrl":"/api/snapshots/raw/214938","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185052/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html?wbdisable=false#ha_snapshot=214938","mimeType":"text/html","statusCode":200}